149 related articles for article (PubMed ID: 16108294)
1. "I'm going to die of something anyway": women's perceptions of tamoxifen for breast cancer risk reduction.
Paterniti DA; Melnikow J; Nuovo J; Henderson S; DeGregorio M; Kuppermann M; Nease R
Ethn Dis; 2005; 15(3):365-72. PubMed ID: 16108294
[TBL] [Abstract][Full Text] [Related]
2. Preferences of Women Evaluating Risks of Tamoxifen (POWER) study of preferences for tamoxifen for breast cancer risk reduction.
Melnikow J; Paterniti D; Azari R; Kuenneth C; Birch S; Kuppermann M; Nuovo J; Keyzer J; Henderson S
Cancer; 2005 May; 103(10):1996-2005. PubMed ID: 15825209
[TBL] [Abstract][Full Text] [Related]
3. Healthy women with a family history of breast cancer: impact of a tailored genetic counseling intervention on risk perception, knowledge, and menopausal therapy decision making.
Matloff ET; Moyer A; Shannon KM; Niendorf KB; Col NF
J Womens Health (Larchmt); 2006 Sep; 15(7):843-56. PubMed ID: 16999640
[TBL] [Abstract][Full Text] [Related]
4. Recruitment strategies for minority participation: challenges and cost lessons from the POWER interview.
Keyzer JF; Melnikow J; Kuppermann M; Birch S; Kuenneth C; Nuovo J; Azari R; Oto-Kent D; Rooney M
Ethn Dis; 2005; 15(3):395-406. PubMed ID: 16108298
[TBL] [Abstract][Full Text] [Related]
5. Decision-making about tamoxifen in women at high risk for breast cancer: clinical and psychological factors.
Bober SL; Hoke LA; Duda RB; Regan MM; Tung NM
J Clin Oncol; 2004 Dec; 22(24):4951-7. PubMed ID: 15598980
[TBL] [Abstract][Full Text] [Related]
6. Providing accurate information to women about tamoxifen therapy for breast cancer: current indications, effects, and controversies.
Pasacreta JV; McCorkle R
Oncol Nurs Forum; 1998 Oct; 25(9):1577-83. PubMed ID: 9802053
[TBL] [Abstract][Full Text] [Related]
7. How should we inform women at higher risk of breast cancer about tamoxifen? An approach with a decision guide.
McKay A; Martin W; Latosinsky S
Breast Cancer Res Treat; 2005 Nov; 94(2):153-9. PubMed ID: 16261414
[TBL] [Abstract][Full Text] [Related]
8. Breast cancer risk in primary care: implications for chemoprevention.
Lewis CL; Kinsinger LS; Harris RP; Schwartz RJ
Arch Intern Med; 2004 Sep; 164(17):1897-903. PubMed ID: 15451765
[TBL] [Abstract][Full Text] [Related]
9. Atypia in random periareolar fine-needle aspiration affects the decision of women at high risk to take tamoxifen for breast cancer chemoprevention.
Goldenberg VK; Seewaldt VL; Scott V; Bean GR; Broadwater G; Fabian C; Kimler B; Zalles C; Lipkus IM
Cancer Epidemiol Biomarkers Prev; 2007 May; 16(5):1032-4. PubMed ID: 17507634
[TBL] [Abstract][Full Text] [Related]
10. The effect of physician recommendation on enrollment in the Breast Cancer Chemoprevention Trial.
Kinney AY; Richards C; Vernon SW; Vogel VG
Prev Med; 1998; 27(5 Pt 1):713-9. PubMed ID: 9808803
[TBL] [Abstract][Full Text] [Related]
11. Chemoprevention: drug pricing and mortality: the case of tamoxifen.
Melnikow J; Kuenneth C; Helms LJ; Barnato A; Kuppermann M; Birch S; Nuovo J
Cancer; 2006 Sep; 107(5):950-8. PubMed ID: 16865680
[TBL] [Abstract][Full Text] [Related]
12. Tamoxifen for the prevention of breast cancer: current status of the National Surgical Adjuvant Breast and Bowel Project P-1 study.
Fisher B; Costantino JP; Wickerham DL; Cecchini RS; Cronin WM; Robidoux A; Bevers TB; Kavanah MT; Atkins JN; Margolese RG; Runowicz CD; James JM; Ford LG; Wolmark N
J Natl Cancer Inst; 2005 Nov; 97(22):1652-62. PubMed ID: 16288118
[TBL] [Abstract][Full Text] [Related]
13. Tamoxifen. To take or not to take. That is the question.
Blanchard P
Tex Nurs; 1999 Aug; 73(7):4-5, 7. PubMed ID: 11949057
[No Abstract] [Full Text] [Related]
14. Women's views on chemoprevention of breast cancer: qualitative study.
Heisey R; Pimlott N; Clemons M; Cummings S; Drummond N
Can Fam Physician; 2006 May; 52(5):624-5. PubMed ID: 17327893
[TBL] [Abstract][Full Text] [Related]
15. Feasibility of a telephone survey to recruit health maintenance organization members into a tamoxifen chemoprevention trial.
Daly M; Seay J; Balshem A; Lerman C; Engstrom P
Cancer Epidemiol Biomarkers Prev; 1992; 1(5):413-6. PubMed ID: 1305474
[TBL] [Abstract][Full Text] [Related]
16. CAPRELA (Cancer Prevention for Latinas): findings of a pilot study in Winston-Salem, Forsyth County.
Koval AE; Riganti AA; Foley KL
N C Med J; 2006; 67(1):9-15. PubMed ID: 16550986
[TBL] [Abstract][Full Text] [Related]
17. Prophylaxis approach to a-symptomatic post-menopausal women: breast cancer.
Aguas F; Martins A; Gomes TP; de Sousa M; Silva DP;
Maturitas; 2005 Nov; 52 Suppl 1():S23-31. PubMed ID: 16126355
[TBL] [Abstract][Full Text] [Related]
18. Women's perceptions of the effectiveness of telephone support and education on their adjustment to breast cancer.
Chamberlain Wilmoth M; Tulman L; Coleman EA; Stewart CB; Samarel N
Oncol Nurs Forum; 2006 Jan; 33(1):138-44. PubMed ID: 16470242
[TBL] [Abstract][Full Text] [Related]
19. Tamoxifen for the prevention of breast cancer: late results of the Italian Randomized Tamoxifen Prevention Trial among women with hysterectomy.
Veronesi U; Maisonneuve P; Rotmensz N; Bonanni B; Boyle P; Viale G; Costa A; Sacchini V; Travaglini R; D'Aiuto G; Oliviero P; Lovison F; Gucciardo G; del Turco MR; Muraca MG; Pizzichetta MA; Conforti S; Decensi A;
J Natl Cancer Inst; 2007 May; 99(9):727-37. PubMed ID: 17470740
[TBL] [Abstract][Full Text] [Related]
20. A qualitative study of factors affecting chemotherapy use in older women with breast cancer: barriers, promoters, and implications for intervention.
Kreling B; Figueiredo MI; Sheppard VL; Mandelblatt JS
Psychooncology; 2006 Dec; 15(12):1065-76. PubMed ID: 16598833
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
